Camilla Zecchetto

5PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2023
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma.

Silvia Pietrobono, Fabio Sabbadini, Monica Bertolini

|Oct 09, 2020
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma.

Valeria Merz, Camilla Zecchetto, Davide Melisi

|Jun 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer.

Valeria Merz, Camilla Zecchetto, Raffaela Santoro

|Jan 04, 2020
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer.

Alessandro Cavaliere, Valeria Merz, Simona Casalino

Pageof 1